| Serial Number | 79404951 |
| Word Mark | MULTIGEN |
| Filing Date | Tuesday, July 9, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 3, 2026 |
| Goods and Services | Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); chemical substances for use in the production of drugs; biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs); none of the foregoing for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies |
| Goods and Services | Collating of data in computer databases; computerized file management; data processing; automated processing of medical and pharmaceutical data; compilation of statistical data relating to medical research and development; computer database management; none of the foregoing services for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies |
| Goods and Services | chemical and biochemical substances for pharmaceutical or veterinary use screened by means of stabilized proteins, namely, small molecules and antibodies for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; veterinary products, namely, antigens and reagents for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; none of the foregoing for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies |
| Goods and Services | Medical and pharmacological research services; pharmaceutical drug development services; laboratory research services relating to pharmaceuticals; research and development of vaccines and medicines; scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); design of computer databases; updating of database software; data warehousing; provision of information and data relating to medical research and development; rendering of computer graphics featuring digital image correction for research and development; computer graphic design services featuring data and image processing services for making three dimensional models; non-medical graphic design featuring digital imaging services; optical imaging for use in research and development of medicines; imaging via computers for use in research and development of medicines; graphic design services for generating and processing data and images for making three dimensional models for use in research and development of medicines; none of the foregoing services for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 26, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 26, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Confo Therapeutics NV |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | Confo Therapeutics NV |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | Confo Therapeutics N.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | BE |
| Event Date | Event Description |
| Thursday, September 26, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 27, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 27, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, December 31, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 1, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 31, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, February 6, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, February 6, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, February 14, 2025 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Saturday, February 22, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, June 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 12, 2025 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Monday, October 27, 2025 | FINAL REFUSAL WRITTEN |
| Monday, October 27, 2025 | FINAL REFUSAL E-MAILED |
| Monday, October 27, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, December 5, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, December 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 5, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 6, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 13, 2026 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 14, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 28, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 29, 2026 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 3, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 3, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |